Sponsor study identifier
observational
80
1 country
1
Study Start
August 1, 2019
Actual (reported)Primary Completion
November 30, 2020
Actual (reported)Study Completion
December 31, 2020
Actual (reported)Short Actives Lives Survey is a common tool used to measure physical activity in the UK population. Self-reported measures such as the Short Active Lives Survey can be prone to bias. As such, during project evaluations, benefits may be exaggerated due to over-reporting of physical activity or downplayed due to underreporting of physical activity. There is also a lack of research reporting the typical short-term and long-term changes in physical activity (measured by the Short Active Lives Survey) in people with chronic lung conditions who are not receiving support to become active (i.e. usual care, control groups). Accelerometers are small lightweight activity monitors that can be worn on the waist. These monitors are known to provide accurate and reliable objective assessment of physical activity in people with lung conditions. This research study will recruit a cohort of inactive people with lung conditions and determine changes in physical activity measured by both the Short Active Lives Survey and one of the most valid accelerometers used in people with lung conditions (Actigraph GT3X). The study will also evaluate how these physical activity measures relate to general health (health status and health care use) of people with lung conditions over 12 months. This study will provide information on the usefulness of using the Short Active Lives Survey in the future for measuring physical activity in people with lung conditions.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2020
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 1, 2019
Actual (reported)September 3, 2019
Actual (reported)September 6, 2019
Actual (reported)November 30, 2020
Actual (reported)December 31, 2020
Actual (reported)Minutes of self-reported moderate intensity equivalent physical activity per week
Short Active Lives Survey
Baseline to 12 months
Accelerometer measured physical activity: time (minutes per day) spent in moderate intensity activity
Baseline to 12 months
Accelerometer measured physical activity: time (minutes per week) spent in light activity
Baseline to 12 months
Accelerometer measured physical activity including: time (minutes per week) spent in vigorous activity
Baseline to 12 months
Accelerometer measured physical activity: time (minutes per day) spent in sedentary state
Baseline to 12 months
Accelerometer measured physical activity: average daily steps
Baseline to 12 months
People with a chronic lung condition who are physically inactive
The eligibility criteria has been designed to be as broad as possible so that findings can be generalisable to the wider population of inactive people with lung conditions. The main study population will be recruited via convenience sampling at the participant identification centres within Lincolnshire Community Health Services, South Lincolnshire CCG, South West Lincolnshire CCG, Lincolnshire East CCG, Lincolnshire West CCG and United Lincolnshire Hospitals NHS Trust.
University of Lincoln
Lincoln, Lincolnshire, LN6 7TS, United Kingdom
Arwel W Jones, PhD
University of Lincoln
80 participants (actual enrollment reported by the registry).
First Submitted
September 3, 2019
First Posted
September 6, 2019
Study Start
August 1, 2019
Actual (reported)Post-Market Optimization Study of the EMPOWER® RF Catheter to Ablate Soft Tissue Lesions in the Lung
Contact the study team to confirm eligibility.
Primary Completion
November 30, 2020
Actual (reported)Study Completion
December 31, 2020
Actual (reported)Last Updated
April 27, 2021
Record last verified: 2020-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: